Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from MPS Limited ( (IN:MPSLTD) ).
MPS North America LLC, a wholly owned subsidiary of MPS Limited, has signed a stock purchase agreement to acquire 100% of Unbound Medicine, Inc., a U.S.-based healthcare learning technology company, for USD 16.5 million, subject to customary adjustments. Unbound Medicine, which generated USD 8.88 million in revenue in 2024, provides mobile-first, AI-enabled clinical decision-support and medical education platforms to more than 480 institutional customers, including medical schools, hospital systems and healthcare associations across the U.S. and Canada, largely on a subscription model with high retention rates. The deal marks MPS’s formal entry into the healthcare and medical information technology segment, aligning with its strategy to pivot toward scalable, profitable businesses and supporting its long-term goal of surpassing INR 1,500 crore in revenue by FY28, while broadening its customer base into critical healthcare and medical education segments and strengthening its recurring revenue profile.
More about MPS Limited
MPS Limited is a technology-enabled content and learning solutions company with core strengths in digital publishing, learning platforms and technology-enabled content services, serving strategic customers globally. Through its wholly owned subsidiary MPS North America LLC, the company is increasingly using disciplined capital allocation and targeted acquisitions to expand into high-growth, knowledge-intensive verticals adjacent to its core offerings.
Average Trading Volume: 1,190
Technical Sentiment Signal: Buy
Current Market Cap: 32.01B INR
For detailed information about MPSLTD stock, go to TipRanks’ Stock Analysis page.